Table 3 Summary statistics

Utilization – DDD per 1,000 capita per year, Mean (SD)

5.04 (34.38)

10.18 (47.46)

Price per DDD per 1,000 capita, Mean (SD)

2.43 (14.20)

2.68 (15.73)

Market Concentration (HHI) at ATC-4, Mean (SD)

0.37 (0.23)

0.32 (0.23)

Generic Competition (Total DDDs), Mean (SD)

389.15 (1815.12)

276.66 (979.18)

Therapeutic group at ATC Level 1, N (%)

 A – Alimentary tract and metabolism

57 (10.73)

68 (11.06)

 B – Blood and blood forming organs

69 (12.99)

75 (12.20)

 C – Cardiovascular system

65 (12.24)

77 (12.52)

 D – Dermatalogicals

8 (1.51)

10 (1.63)

 G – Genito – urinary system and sex hormones

43 (8.10)

50 (8.13)

 J – Antiinfectives for systemic use

22 (4.14)

22 (3.58)

 L – Antineoplastic agents and immunomodulating agents

93 (17.51)

109 (17.72)

 M – Musculo – skeletal system

8 (1.51)

14 (2.28)

 N – Nervous system

142 (26.74)

158 (25.69)

 R – Respiratory system

23 (4.33)

30 (4.88)

 S – Sensory Organs

1 (0.19)

2 (0.33)

Year(s) since registration, N (%)

 Year 1

118 (22.22)

149 (24.23)

 Year 2

136 (25.61)

149 (24.23)

 Year 3

116 (21.85)

118 (19.19)

 Year 4

96 (18.08)

98 (15.93)

 Year 5

43 (8.10)

48 (7.80)